ID   SPI1_RAT                Reviewed;         271 AA.
AC   Q6BDS1; Q5BK69;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   24-JAN-2024, entry version 131.
DE   RecName: Full=Transcription factor PU.1;
GN   Name=Spi1; Synonyms=Sfpi1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION AS A TRANSCRIPTION FACTOR, AND
RP   MUTAGENESIS OF GLY-41 AND SER-45.
RX   PubMed=15304324; DOI=10.1016/j.febslet.2004.07.008;
RA   Nishiyama C., Masuoka N., Nishiyama M., Ito T., Yamane H., Okumura K.,
RA   Ogawa H.;
RT   "Evidence against requirement of Ser41 and Ser45 for function of PU.1:
RT   molecular cloning of rat PU.1.";
RL   FEBS Lett. 572:57-64(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Pioneer transcription factor, which controls hematopoietic
CC       cell fate by decompacting stem cell heterochromatin and allowing other
CC       transcription factors to enter otherwise inaccessible genomic sites.
CC       Once in open chromatin, can directly control gene expression by binding
CC       genetic regulatory elements and can also more broadly influence
CC       transcription by recruiting transcription factors, such as interferon
CC       regulatory factors (IRFs), to otherwise inaccessible genomic regions
CC       (By similarity). Transcriptionally activates genes important for
CC       myeloid and lymphoid lineages, such as CSF1R or FCER1A
CC       (PubMed:15304324). Transcriptional activation from certain promoters,
CC       possibly containing low affinity binding sites, is achieved
CC       cooperatively with other transcription factors. FCER1A transactivation
CC       is achieved in cooperation with GATA1 (PubMed:15304324). May be
CC       particularly important for the pro- to pre-B cell transition. Binds
CC       (via the ETS domain) onto the purine-rich DNA core sequence 5'-GAGGAA-
CC       3', also known as the PU-box (By similarity). In vitro can bind RNA and
CC       interfere with pre-mRNA splicing (By similarity).
CC       {ECO:0000250|UniProtKB:P17433, ECO:0000250|UniProtKB:P17947,
CC       ECO:0000269|PubMed:15304324}.
CC   -!- ACTIVITY REGULATION: Transcriptional activity at macrophage-specific
CC       genes is inhibited by interaction with GFI1, which results in the
CC       inhibition of SPI1-induced macrophage differentiation of myeloid
CC       progenitor cells, but not that of the granulocyte lineage.
CC       {ECO:0000250|UniProtKB:P17433}.
CC   -!- SUBUNIT: Binds DNA as a monomer. Can form homomers (By similarity).
CC       Directly interacts with CEBPD/NF-IL6-beta; this interaction does not
CC       affect DNA-binding properties of each partner. Interacts with
CC       NONO/p54(nrb) (By similarity). Interacts with RUNX1/AML1. Interacts
CC       with GFI1; the interaction represses SPI1 transcriptional activity,
CC       hence blocks SPI1-induced macrophage differentiation of myeloid
CC       progenitor cells. Interacts with CEBPE. Interacts with IRF4/Pip and
CC       IRF8. Interacts with JUN. Interacts with RB1. Interacts with TBP (By
CC       similarity). {ECO:0000250|UniProtKB:P17433,
CC       ECO:0000250|UniProtKB:P17947}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00237}.
CC   -!- SIMILARITY: Belongs to the ETS family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB154364; BAD35169.1; -; mRNA.
DR   EMBL; BC091185; AAH91185.1; -; mRNA.
DR   RefSeq; NP_001005892.1; NM_001005892.2.
DR   AlphaFoldDB; Q6BDS1; -.
DR   SMR; Q6BDS1; -.
DR   BioGRID; 265745; 1.
DR   IntAct; Q6BDS1; 1.
DR   STRING; 10116.ENSRNOP00000016306; -.
DR   iPTMnet; Q6BDS1; -.
DR   PhosphoSitePlus; Q6BDS1; -.
DR   PaxDb; 10116-ENSRNOP00000016306; -.
DR   GeneID; 366126; -.
DR   KEGG; rno:366126; -.
DR   UCSC; RGD:1359607; rat.
DR   AGR; RGD:1359607; -.
DR   CTD; 6688; -.
DR   RGD; 1359607; Spi1.
DR   VEuPathDB; HostDB:ENSRNOG00000012172; -.
DR   eggNOG; KOG3805; Eukaryota.
DR   HOGENOM; CLU_066451_0_0_1; -.
DR   InParanoid; Q6BDS1; -.
DR   PhylomeDB; Q6BDS1; -.
DR   TreeFam; TF352494; -.
DR   PRO; PR:Q6BDS1; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000012172; Expressed in spleen and 18 other cell types or tissues.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001216; F:DNA-binding transcription activator activity; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0001217; F:DNA-binding transcription repressor activity; ISO:RGD.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0051525; F:NFAT protein binding; ISO:RGD.
DR   GO; GO:0140311; F:protein sequestering activity; ISO:RGD.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0097677; F:STAT family protein binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0060033; P:anatomical structure regression; ISO:RGD.
DR   GO; GO:1902262; P:apoptotic process involved in blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0071361; P:cellular response to ethanol; IEP:RGD.
DR   GO; GO:0002357; P:defense response to tumor cell; ISO:RGD.
DR   GO; GO:0098508; P:endothelial to hematopoietic transition; ISO:RGD.
DR   GO; GO:0030218; P:erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0002316; P:follicular B cell differentiation; ISO:RGD.
DR   GO; GO:0002314; P:germinal center B cell differentiation; ISO:RGD.
DR   GO; GO:0030851; P:granulocyte differentiation; ISO:RGD.
DR   GO; GO:0002327; P:immature B cell differentiation; ISO:RGD.
DR   GO; GO:0070102; P:interleukin-6-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0030098; P:lymphocyte differentiation; ISO:RGD.
DR   GO; GO:0002320; P:lymphoid progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0030225; P:macrophage differentiation; ISO:RGD.
DR   GO; GO:0043011; P:myeloid dendritic cell differentiation; ISO:RGD.
DR   GO; GO:0002573; P:myeloid leukocyte differentiation; ISO:RGD.
DR   GO; GO:1904178; P:negative regulation of adipose tissue development; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0045347; P:negative regulation of MHC class II biosynthetic process; ISO:RGD.
DR   GO; GO:0043314; P:negative regulation of neutrophil degranulation; ISO:RGD.
DR   GO; GO:1901223; P:negative regulation of non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0120186; P:negative regulation of protein localization to chromatin; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0090402; P:oncogene-induced cell senescence; ISO:RGD.
DR   GO; GO:0030316; P:osteoclast differentiation; IEP:RGD.
DR   GO; GO:1904238; P:pericyte cell differentiation; ISO:RGD.
DR   GO; GO:1905036; P:positive regulation of antifungal innate immune response; ISO:RGD.
DR   GO; GO:0045579; P:positive regulation of B cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:1904151; P:positive regulation of microglial cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:2000529; P:positive regulation of myeloid dendritic cell chemotaxis; ISO:RGD.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0002572; P:pro-T cell differentiation; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045646; P:regulation of erythrocyte differentiation; ISO:RGD.
DR   GO; GO:1905453; P:regulation of myeloid progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISO:RGD.
DR   GO; GO:0036462; P:TRAIL-activated apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0045815; P:transcription initiation-coupled chromatin remodeling; ISS:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001944; P:vasculature development; ISO:RGD.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR000418; Ets_dom.
DR   InterPro; IPR046328; ETS_fam.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11849; ETS; 1.
DR   PANTHER; PTHR11849:SF16; TRANSCRIPTION FACTOR PU.1; 1.
DR   Pfam; PF00178; Ets; 1.
DR   PRINTS; PR00454; ETSDOMAIN.
DR   SMART; SM00413; ETS; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
DR   PROSITE; PS00345; ETS_DOMAIN_1; 1.
DR   PROSITE; PS00346; ETS_DOMAIN_2; 1.
DR   PROSITE; PS50061; ETS_DOMAIN_3; 1.
PE   1: Evidence at protein level;
KW   Activator; Developmental protein; DNA-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; RNA-binding; Transcription; Transcription regulation.
FT   CHAIN           1..271
FT                   /note="Transcription factor PU.1"
FT                   /id="PRO_0000204135"
FT   DNA_BIND        171..254
FT                   /note="ETS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00237"
FT   REGION          124..164
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        131..145
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         218
FT                   /ligand="DNA"
FT                   /ligand_id="ChEBI:CHEBI:16991"
FT                   /note="forms a salt bridge with the phosphate backbone of
FT                   the opposite strand downstream of the GGAA core sequence"
FT                   /evidence="ECO:0000250|UniProtKB:P17433"
FT   BINDING         231
FT                   /ligand="DNA"
FT                   /ligand_id="ChEBI:CHEBI:16991"
FT                   /note="contacts bases in the GGAA sequence in the major
FT                   groove"
FT                   /evidence="ECO:0000250|UniProtKB:P17433"
FT   BINDING         234
FT                   /ligand="DNA"
FT                   /ligand_id="ChEBI:CHEBI:16991"
FT                   /note="contacts bases in the GGAA sequence in the major
FT                   groove"
FT                   /evidence="ECO:0000250|UniProtKB:P17433"
FT   BINDING         244
FT                   /ligand="DNA"
FT                   /ligand_id="ChEBI:CHEBI:16991"
FT                   /note="contacts the phosphate backbone of the GGAA sequence
FT                   in the minor groove upstream"
FT                   /evidence="ECO:0000250|UniProtKB:P17433"
FT   MOD_RES         141
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17947"
FT   MOD_RES         147
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17947"
FT   MUTAGEN         41
FT                   /note="G->A,S: No effect on transcriptional activation of
FT                   CSF1R or FCER1A promoter."
FT                   /evidence="ECO:0000269|PubMed:15304324"
FT   MUTAGEN         45
FT                   /note="S->A: No effect on transcriptional activation of
FT                   CSF1R or FCER1A promoter."
FT                   /evidence="ECO:0000269|PubMed:15304324"
SQ   SEQUENCE   271 AA;  31089 MW;  CDD9F21BAD449608 CRC64;
     MLQACKMEGF PLVAPPSDEL VTYESELYQR QTHDYYSLIG GDGDSHSDHY WDFSTHHVHS
     EFESFPENHF TELQSVQPPQ LQQLYRHMEL EQMHVLDTPM APPHASLSHQ VSYMPRVCFP
     YPPLSPAHQQ SSDEEEGERQ SPPLEVSDGE ADGLEPGPGL LHGETGSKKK IRLYQFLLDL
     LRSGDMKDSI WWVDKDKGTF QFSSKHKEAL AHRWGIQKGN RKKMTYQKMA RALRNYGKTG
     EVKKVKKKLT YQFSGEVLGR GGLAERRLPP H
//
